TherapeuticsMD reported $20K in Interest Expense on Debt for its fiscal quarter ending in September of 2023.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Cipla INR 131.3M 9M Mar/2026
Compugen USD 954K 116K Sep/2025
CSL USD 215M 111M Dec/2025
Grifols EUR 156.07M 31.46M Sep/2025
Pfizer USD 671M 40M Mar/2026
TherapeuticsMD USD 20K 25K Sep/2023